For Investors

Close

Incyte International Locations

NORTH AMERICA—
HEADQUARTERS

FINLAND

JAPAN

SWEDEN

EUROPE—
HEADQUARTERS

FRANCE

THE NETHERLANDS

SWITZERLAND

AUSTRIA

GERMANY

NORWAY

UNITED KINGDOM

DENMARK

ITALY

SPAIN

Home > Investor Relations

Investor Relations

Overview

Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.

Events & Presentations

Upcoming

Monday March 2, 2020 at 11:20 AM EST
Cowen and Company’s 40th Annual Health Care Conference

View All Events

Prior

Thursday February 13, 2020 at 8:00 AM EST
Q4 2019 Incyte Corporation Earnings Conference Call

Monday January 13, 2020 at 9:00 AM PST
J. P. Morgan 38th Annual Healthcare Conference Q/A Session

Monday January 13, 2020 at 8:30 AM PST
J. P. Morgan 38th Annual Healthcare Conference Presentation

View All Events

Press Releases

February 19, 2020

Incyte Announces Launch of the Incyte Ingenuity Award Program to Recognize Innovation Within the GVHD Community


February 19, 2020

Incyte Announces Positive Topline Results From Phase 3 TRuE-AD Program Evaluating Ruxolitinib Cream in Patients With Atopic Dermatitis


February 13, 2020

Incyte Reports 2019 Fourth Quarter and Year-End Financial Results and Provides 2020 Financial Guidance and Updates on Key Clinical Programs


View All Releases

Investor Contacts

Michael Booth D.Phil
Division VP, Investor Relations & Corporate Responsibility
Phone: 302.498.5914
mbooth@incyte.com

Lauren Ayala, MBA
Senior Director, Investor Relations & Corporate Responsibility
Phone: 302.498.6141
layala@incyte.com

Christine Chiou
Senior Director, Investor Relations
Phone: 302.274.4773
cchiou@incyte.com

Copyright West LLC. Minimum 15 minutes delayed.

Annual Reports

Quarterly Reports

RSS Feeds


All Press Releases

All Events

All SEC Filings